Pages that link to "Q68508604"
Jump to navigation
Jump to search
The following pages link to Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer (Q68508604):
Displaying 5 items.
- Different anthracycline derivates for reducing cardiotoxicity in cancer patients (Q24235507) (← links)
- Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer (Q36657495) (← links)
- Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy (Q40488017) (← links)
- A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer (Q58614990) (← links)
- Dose dependence of the cytokinetic and cytotoxic effects of epirubicin in vitro (Q68202641) (← links)